Sunshine Lake Pharma Co., Ltd. (HKG:6887)
53.75
+0.50 (0.94%)
Last updated: Sep 10, 2025, 1:29 PM HKT
Sunshine Lake Pharma Revenue
In the year 2024, Sunshine Lake Pharma had annual revenue of 3.72B CNY, down -40.84%. Sunshine Lake Pharma had revenue of 1.27B in the half year ending December 31, 2024, a decrease of -48.24%.
Revenue
3.72B CNY
Revenue Growth
-40.84%
P/S Ratio
6.71
Revenue / Employee
766.05K CNY
Employees
4,861
Market Cap
26.61B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.72B | -2.57B | -40.84% |
Dec 31, 2023 | 6.29B | 2.55B | 68.08% |
Dec 31, 2022 | 3.74B | 2.83B | 309.83% |
Dec 31, 2021 | 913.79M | -1.43B | -61.08% |
Dec 31, 2020 | 2.35B | -3.88B | -62.27% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
WuXi Biologics | 21.98B |
Akeso | 2.75B |
CSPC Pharmaceutical Group | 28.49B |